Global Biobanking Sample Market By Product Type (Blood Products, Human Tissues) And By End-Users/Application (Regenerative Medicine, Life Science Research) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Biobanking Sample market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Biobanking Sample market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Biobanking Sample industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Biobanking Sample ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Biobanking Sample market.

The following manufacturers are covered in this report:
  • Thermo Fisher Scientific Inc. (U.S.)
  • Tecan Group Ltd. (Switzerland)
  • Qiagen N.V. (Germany)
  • Hamilton Company (U.S.)
  • Brooks Automation (U.S.)
  • TTP Labtech Ltd (U.K.)
  • VWR Corporation (U.S.)
  • Promega Corporation (U.S.)
  • Worthington Industries [(Taylor Wharton, U.S.)]
  • Chart Industries (U.S.)
  • Becton, Dickinson and Company (U.S.)
  • Merck KGaA (Germany)
  • Micronic (Netherlands)
  • LVL Technologies GmbH & Co. KG (Germany)
  • Panasonic Healthcare Holdings Co. Ltd (Japan)
  • Greiner Bio One [Greiner Holding AG, Austria)]
  • Biokryo GmbH (Germany)

The report estimates on the Biobanking Sample market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Biobanking Sample market report consist of all leading industry players, Biobanking Sample business sections, company profile, revenue supply by Biobanking Sample industry sections, global Biobanking Sample market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Biobanking Sample market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Biobanking Sample market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Biobanking Sample market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Biobanking Sample market.

Report Opportunity: Global Biobanking Sample Market

This report delivers an analytical examination of the Biobanking Sample market summarized in broad sections such as
  1. Biobanking Sample Market Summary
  2. Key Commercial Growths in the Biobanking Sample Industry
  3. Market Dynamics Affecting the Biobanking Sample Industry
  4. Important Market Trends and Future Development Scenario of the Biobanking Sample Market
  5. Biobanking Sample Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Biobanking Sample Industry
  7. Positioning of Main Market Players in the Biobanking Sample Industry
  8. Biobanking Sample Market Revenue and Forecast, by Application, 2018 - 2028
  9. Biobanking Sample Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Biobanking Sample Market Revenue and Forecast, by Geography, 2018 - 2028
Biobanking Sample Market Segmentation:

The report provides detailed examination of the Biobanking Sample market on the basis of various segments such as type, application and end-use industry. The Biobanking Sample market is segmented as follows:

Biobanking Sample Market, by Type:
  • Blood Products
  • Human Tissues
  • Nucleic Acids
  • Cell Lines
  • Biological Fluids
  • Human Waste Products
Biobanking Sample Market, by Application:
  • Regenerative Medicine
  • Life Science Research
  • Clinical Research
Geographic Coverage

The report on the Biobanking Sample market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Biobanking Sample Market Revenue and Forecast
  • U.S.
  • Canada
Europe Biobanking Sample Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Biobanking Sample Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Biobanking Sample Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Biobanking Sample Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Biobanking Sample Market Snapshot
          2.1.1. Global Biobanking Sample Market By Type,2019
               2.1.1.1.Blood Products
               2.1.1.2.Human Tissues
               2.1.1.3.Nucleic Acids
               2.1.1.4.Cell Lines
               2.1.1.5.Biological Fluids
               2.1.1.6.Human Waste Products
          2.1.2. Global Biobanking Sample Market By Application,2019
               2.1.2.1.Regenerative Medicine
               2.1.2.2.Life Science Research
               2.1.2.3.Clinical Research
          2.1.3. Global Biobanking Sample Market By End-use,2019
          2.1.4. Global Biobanking Sample Market By Geography,2019

3. Global Biobanking Sample Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Biobanking Sample Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Biobanking Sample Market Size (US$), By Type, 2018 – 2028

5. Global Biobanking Sample Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Biobanking Sample Market Size (US$), By Application, 2018 – 2028

6. Global Biobanking Sample Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Biobanking Sample Market Size (US$), By End-use, 2018 – 2028

7. Global Biobanking Sample Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Biobanking Sample Market Analysis, 2018 – 2028 
          7.2.1. North America Biobanking Sample Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Biobanking Sample Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Biobanking Sample Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Biobanking Sample Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Biobanking Sample Market Analysis, 2018 – 2028 
          7.3.1.  Europe Biobanking Sample Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Biobanking Sample Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Biobanking Sample Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Biobanking Sample Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Biobanking Sample Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Biobanking Sample Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Biobanking Sample Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Biobanking Sample Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Biobanking Sample Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Biobanking Sample Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Biobanking Sample Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Biobanking Sample Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Biobanking Sample Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Biobanking Sample Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Biobanking Sample Market Analysis, 2018 – 2028 
          7.6.1.  MEA Biobanking Sample Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Biobanking Sample Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Biobanking Sample Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Biobanking Sample Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Biobanking Sample Providers
        8.4.1 Thermo Fisher Scientific Inc. (U.S.)
                8.1.1 Business Description
                8.1.2 Thermo Fisher Scientific Inc. (U.S.) Geographic Operations
                8.1.3 Thermo Fisher Scientific Inc. (U.S.) Financial Information
                8.1.4 Thermo Fisher Scientific Inc. (U.S.) Product Positions/Portfolio
                8.1.5 Thermo Fisher Scientific Inc. (U.S.) Key Developments
        8.4.2 Tecan Group Ltd. (Switzerland)
                8.2.1 Business Description
                8.2.2 Tecan Group Ltd. (Switzerland) Geographic Operations
                8.2.3 Tecan Group Ltd. (Switzerland) Financial Information
                8.2.4 Tecan Group Ltd. (Switzerland) Product Positions/Portfolio
                8.2.5 Tecan Group Ltd. (Switzerland) Key Developments
        8.4.3 Qiagen N.V. (Germany)
                8.3.1 Business Description
                8.3.2 Qiagen N.V. (Germany) Geographic Operations
                8.3.3 Qiagen N.V. (Germany) Financial Information
                8.3.4 Qiagen N.V. (Germany) Product Positions/Portfolio
                8.3.5 Qiagen N.V. (Germany) Key Developments
        8.4.4 Hamilton Company (U.S.)
                8.4.1 Business Description
                8.4.2 Hamilton Company (U.S.) Geographic Operations
                8.4.3 Hamilton Company (U.S.) Financial Information
                8.4.4 Hamilton Company (U.S.) Product Positions/Portfolio
                8.4.5 Hamilton Company (U.S.) Key Developments
        8.4.5 Brooks Automation (U.S.)
                8.5.1 Business Description
                8.5.2 Brooks Automation (U.S.) Geographic Operations
                8.5.3 Brooks Automation (U.S.) Financial Information
                8.5.4 Brooks Automation (U.S.) Product Positions/Portfolio
                8.5.5 Brooks Automation (U.S.) Key Developments
        8.4.6 TTP Labtech Ltd (U.K.)
                8.6.1 Business Description
                8.6.2 TTP Labtech Ltd (U.K.) Geographic Operations
                8.6.3 TTP Labtech Ltd (U.K.) Financial Information
                8.6.4 TTP Labtech Ltd (U.K.) Product Positions/Portfolio
                8.6.5 TTP Labtech Ltd (U.K.) Key Developments
        8.4.7 VWR Corporation (U.S.)
                8.7.1 Business Description
                8.7.2 VWR Corporation (U.S.) Geographic Operations
                8.7.3 VWR Corporation (U.S.) Financial Information
                8.7.4 VWR Corporation (U.S.) Product Positions/Portfolio
                8.7.5 VWR Corporation (U.S.) Key Developments
        8.4.8 Promega Corporation (U.S.)
                8.8.1 Business Description
                8.8.2 Promega Corporation (U.S.) Geographic Operations
                8.8.3 Promega Corporation (U.S.) Financial Information
                8.8.4 Promega Corporation (U.S.) Product Positions/Portfolio
                8.8.5 Promega Corporation (U.S.) Key Developments
        8.4.9 Worthington Industries [(Taylor Wharton, U.S.)]
                8.9.1 Business Description
                8.9.2 Worthington Industries [(Taylor Wharton, U.S.)] Geographic Operations
                8.9.3 Worthington Industries [(Taylor Wharton, U.S.)] Financial Information
                8.9.4 Worthington Industries [(Taylor Wharton, U.S.)] Product Positions/Portfolio
                8.9.5 Worthington Industries [(Taylor Wharton, U.S.)] Key Developments
        8.4.10 Chart Industries (U.S.)
                8.10.1 Business Description
                8.10.2 Chart Industries (U.S.) Geographic Operations
                8.10.3 Chart Industries (U.S.) Financial Information
                8.10.4 Chart Industries (U.S.) Product Positions/Portfolio
                8.10.5 Chart Industries (U.S.) Key Developments
        8.4.11 Becton, Dickinson and Company (U.S.)
                8.11.1 Business Description
                8.11.2 Becton, Dickinson and Company (U.S.) Geographic Operations
                8.11.3 Becton, Dickinson and Company (U.S.) Financial Information
                8.11.4 Becton, Dickinson and Company (U.S.) Product Positions/Portfolio
                8.11.5 Becton, Dickinson and Company (U.S.) Key Developments
        8.4.12 Merck KGaA (Germany)
                8.12.1 Business Description
                8.12.2 Merck KGaA (Germany) Geographic Operations
                8.12.3 Merck KGaA (Germany) Financial Information
                8.12.4 Merck KGaA (Germany) Product Positions/Portfolio
                8.12.5 Merck KGaA (Germany) Key Developments
        8.4.13 Micronic (Netherlands)
                8.13.1 Business Description
                8.13.2 Micronic (Netherlands) Geographic Operations
                8.13.3 Micronic (Netherlands) Financial Information
                8.13.4 Micronic (Netherlands) Product Positions/Portfolio
                8.13.5 Micronic (Netherlands) Key Developments
        8.4.14 LVL Technologies GmbH & Co. KG (Germany)
                8.14.1 Business Description
                8.14.2 LVL Technologies GmbH & Co. KG (Germany) Geographic Operations
                8.14.3 LVL Technologies GmbH & Co. KG (Germany) Financial Information
                8.14.4 LVL Technologies GmbH & Co. KG (Germany) Product Positions/Portfolio
                8.14.5 LVL Technologies GmbH & Co. KG (Germany) Key Developments
        8.4.15 Panasonic Healthcare Holdings Co. Ltd (Japan)
                8.15.1 Business Description
                8.15.2 Panasonic Healthcare Holdings Co. Ltd (Japan) Geographic Operations
                8.15.3 Panasonic Healthcare Holdings Co. Ltd (Japan) Financial Information
                8.15.4 Panasonic Healthcare Holdings Co. Ltd (Japan) Product Positions/Portfolio
                8.15.5 Panasonic Healthcare Holdings Co. Ltd (Japan) Key Developments
        8.4.16 Greiner Bio One [Greiner Holding AG, Austria)]
                8.16.1 Business Description
                8.16.2 Greiner Bio One [Greiner Holding AG, Austria)] Geographic Operations
                8.16.3 Greiner Bio One [Greiner Holding AG, Austria)] Financial Information
                8.16.4 Greiner Bio One [Greiner Holding AG, Austria)] Product Positions/Portfolio
                8.16.5 Greiner Bio One [Greiner Holding AG, Austria)] Key Developments
        8.4.17 Biokryo GmbH (Germany)
                8.17.1 Business Description
                8.17.2 Biokryo GmbH (Germany) Geographic Operations
                8.17.3 Biokryo GmbH (Germany) Financial Information
                8.17.4 Biokryo GmbH (Germany) Product Positions/Portfolio
                8.17.5 Biokryo GmbH (Germany) Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Biobanking Sample Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Biobanking Sample Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Biobanking Sample Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Biobanking Sample Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Biobanking Sample Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Biobanking Sample Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Biobanking Sample Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Biobanking Sample Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Biobanking Sample Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Biobanking Sample Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Biobanking Sample Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Biobanking Sample Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Biobanking Sample Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Biobanking Sample Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Biobanking Sample Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Biobanking Sample Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Biobanking Sample: Market Segmentation 
FIG. 2 Global Biobanking Sample Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Biobanking Sample Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Biobanking Sample Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Biobanking Sample Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Biobanking Sample Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Biobanking Sample Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Biobanking Sample Providers, 2019
FIG. 11 Global Biobanking Sample Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Biobanking Sample Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Biobanking Sample Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Biobanking Sample Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Biobanking Sample Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Biobanking Sample Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Biobanking Sample Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Biobanking Sample Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Biobanking Sample market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
1272

1823

OUR CLIENT